Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
Go back to Evolent reiterates Q2 and full year guidance for Adjusted EBITDA| (NYSE: EVH) | Delayed: 4.60 +0.01 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.59 | 52 Week High | $26.84 | |||
| Open | $4.54 | 52 Week Low | $8.14 | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.43 | EPS | $0.00 | |||
| Volume | 2,213,089 | |||||

